COMMUNIQUÉS West-GlobeNewswire

Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication
28/05/2026
Online TRT Blood Work Through LabCorp and Quest Diagnostics, Sublingual 4-in-1 ED Medication, Prescription Access, and Pricing Explained Wilmington, DE, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not [...]
CG Oncology to Present at Upcoming Investor Conferences in June
28/05/2026
DALLAS, May 28, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentations at the [...]
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
28/05/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that the Company received a written notice (“Notice”) from the Nasdaq [...]
Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
28/05/2026
ISELIN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg, bevacizumab [...]
Keeps TRT Claims Evaluated: Clinician-Prescribed Testosterone Replacement Therapy Medication Online
28/05/2026
Compounded Testosterone Medication, Injectable TRT, Oral TRT, Enclomiphene Off-Label, Lab Panel, FDA Status, Pricing, and Telehealth Prescribing Rules (2026) New York, NY, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded [...]
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
28/05/2026
BRISBANE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company” or “Pacira”), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform [...]
rYojbaba Rings the Nasdaq Stock Market Opening Bell, Celebrating Its Mission to “Fight Poverty” on the Global Stage
28/05/2026
CEO Ryoji Baba shares the company’s vision of combining the Samurai Spirit with AI and technology to break language barriers and create opportunities for the next generation FUKUOKA, Japan, May 28, 2026 (GLOBE NEWSWIRE [...]
Apogee Therapeutics to Participate in Upcoming June Conferences
28/05/2026
SAN FRANCISCO and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences. Jefferies Global [...]
Parexel to Present Real-World Oncology Research and Launch New Patient-Focused Campaign at ASCO 2026
28/05/2026
Two virtual posters accepted exploring rejections in oncology marketing applications and real-world pulmonary safety of T-DXd in HER2-positive metastatic breast cancer From Insights to Life campaign reinforces Parexel’s [...]
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/05/2026
RESEARCH TRIANGLE PARK, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients [...]
Tarsus to Participate in Upcoming Investor Conferences
28/05/2026
IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: William Blair 46 th [...]
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
28/05/2026
LA JOLLA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that [...]
Allogene Therapeutics Announces Planned CEO Succession
28/05/2026
David Chang, M.D., Ph.D., to Transition from President and Chief Executive Officer Following Eight Years of Outstanding Leadership and Continue to Serve on the Board of Directors Zachary Roberts, M.D., Ph.D., EVP, [...]
MEDIROM Group Reports Q1 2026 Results
29/05/2026
TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview of our business performance and key performance indicators (KPIs) for the first quarter of 2026 (January–March 2026). It also highlights trends [...]
HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance
28/05/2026
Increases Repurchase Program by $1.0 Billion Highlights of the first quarter include: Net income increased 29% to $69.4 million , and net income margin increased to 20% from 16% last year. Adjusted EBITDA increased 17% [...]
Sequana Medical announces results of Annual General Meeting of Shareholders
28/05/2026
Ghent, Belgium, May 28, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION | 28 May 2026, 9:00 pm CEST Ghent, Belgium – 28 May 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " [...]
OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
28/05/2026
First step of a global financing strategy, as the Company is actively engaging with institutional investors in the United States and in Europe Gross proceeds could amount to €19.3 million based on current share price 1 [...]
Medline Inc. announces closing of upsized secondary offering of Class A common stock
28/05/2026
NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.’s Class A common stock by [...]
LB Pharmaceuticals to Participate in Upcoming June Investor Events
28/05/2026
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]

Pages